Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>Organto has completed a restructuring, including realigning and streamlining operations, the sale of underperforming subsidiaries, converting its debt to equity, and a series of private placements.</li>
<li>The Company is now set up for an excellent 2025 and beyond.</li>
<li>Organto grew revenue 291% YoY in Q2 and 194% YoY in Q1, building upon the 48% revenue growth in 2024.</li>
</ul>


Organto has completed a restructuring, including realigning and streamlining operations, the sale of underperforming subsidiaries, converting its debt to equity, and a series of private placements.
The Company is now set up for an excellent 2025 and beyond.
Organto grew revenue 291% YoY in Q2 and 194% YoY in Q1, building upon the 48% revenue growth in 2024.


Organto Foods

OGO: Restructured & Ready to Grow